Loading...
SS Innovations International, Inc.
SSII•NASDAQ
Healthcare
Medical - Devices
$7.18
$-0.02(-0.28%)
SS Innovations International, Inc. (SSII) Financial Performance & Income Statement Overview
Review SS Innovations International, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
251.20%
↑ 251.20%
Operating Income Growth
8.19%
↑ 8.19%
Net Income Growth
8.55%
↑ 8.55%
Operating Cash Flow Growth
29.98%
↑ 29.98%
Operating Margin
-105.30%
↓ 105.30%
Gross Margin
33.23%
↑ 33.23%
Net Profit Margin
-119.66%
↓ 119.66%
ROE
-104.54%
↓ 104.54%
ROIC
-40.29%
↓ 40.29%
SS Innovations International, Inc. (SSII) Income Statement & Financial Overview
Review SS Innovations International, Inc.'s (SSII) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.62M | $3.41M | $4.39M | $6.85M |
| Cost of Revenue | $2.59M | $2.11M | $3.65M | $3.95M |
| Gross Profit | $3.03M | $1.30M | $738071.00 | $2.90M |
| Gross Profit Ratio | $0.54 | $0.38 | $0.17 | $0.42 |
| R&D Expenses | $765412.00 | $1.30M | $30068.00 | $396050.00 |
| SG&A Expenses | $10.50M | $5.07M | $3.48M | $5.22M |
| Operating Expenses | $10.66M | $7.24M | $3.51M | $5.62M |
| Total Costs & Expenses | $13.25M | $9.34M | $7.15M | $9.57M |
| Interest Income | $256914.00 | $310544.00 | $64741.00 | $102941.00 |
| Interest Expense | $80376.00 | $247616.00 | $229521.00 | $183212.00 |
| Depreciation & Amortization | $169721.00 | $119502.00 | $333883.00 | $77189.00 |
| EBITDA | -$7.20M | -$4.76M | -$2.40M | -$2.54M |
| EBITDA Ratio | -$1.28 | -$1.40 | -$0.55 | -$0.37 |
| Operating Income | -$7.63M | -$3.20M | -$2.77M | -$2.72M |
| Operating Income Ratio | -$1.36 | -$0.94 | -$0.63 | -$0.40 |
| Other Income/Expenses (Net) | $176538.00 | -$40715.00 | -$164778.00 | -$80271.00 |
| Income Before Tax | -$7.45M | -$3.25M | -$2.93M | -$2.80M |
| Income Before Tax Ratio | -$1.33 | -$0.95 | -$0.67 | -$0.41 |
| Income Tax Expense | $0.00 | $2.87M | $0.00 | $0.00 |
| Net Income | -$7.45M | -$6.12M | -$2.93M | -$2.80M |
| Net Income Ratio | -$1.33 | -$1.80 | -$0.67 | -$0.41 |
| EPS | -$0.04 | -$0.04 | -$0.02 | -$0.02 |
| Diluted EPS | -$0.04 | -$0.02 | -$0.02 | -$0.02 |
| Weighted Avg Shares Outstanding | $170.78M | $170.78M | $170.74M | $170.74M |
| Weighted Avg Shares Outstanding (Diluted) | $181.89M | $181.89M | $170.74M | $170.74M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan